Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Cash Flow Quality Index
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Cash Flow Quality Index of 0.48x as of September 2025. Operating cash flow of CN¥45.11 Million is below net income of CN¥94.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 605016 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 605016 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year earnings quality comparison for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.. For live market cap and the full company financial profile, see Shandong Bailong Chuangyuan Bio-Tech Co. (605016) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | CN¥135.45 Million | CN¥368.55 Million | ▼ -70.0% |
| 2024 | 1.23x | CN¥300.89 Million | CN¥245.60 Million | ▲ +21.5% |
| 2023 | 1.01x | CN¥194.63 Million | CN¥193.00 Million | ▲ +1.5% |
| 2022 | 0.99x | CN¥149.82 Million | CN¥150.80 Million | ▲ +7.9% |
| 2021 | 0.92x | CN¥96.20 Million | CN¥104.48 Million | ▼ -27.8% |
| 2020 | 1.27x | CN¥121.82 Million | CN¥95.55 Million | ▲ +64.7% |
| 2019 | 0.77x | CN¥64.08 Million | CN¥82.78 Million | ▼ -43.3% |
| 2018 | 1.36x | CN¥89.12 Million | CN¥65.30 Million | ▼ -23.3% |
| 2017 | 1.78x | CN¥113.47 Million | CN¥63.73 Million | ▲ +92.0% |
| 2016 | 0.93x | CN¥60.10 Million | CN¥64.80 Million | — |